"FDA's Proposed Hatch-Waxman Updates – Implications for Generics and Beyond," Northwestern Journal of Technology and Intellectual Property Symposium, Northwestern School of Law, Chicago, IL
Speaking Engagement | 03.11.16
Contacts
Insights
Speaking Engagement | 09.09.26
Speaking Engagement | 05.07.26
Speaking Engagement | 04.29.26
"Styrene: The draft proposal to reclassify in Europe Webinar," Crowell & Moring Webinar.

